Repeat Dose Safety and Efficacy Study for Compound to Treat Anemia

Status:
Completed

Trial end date:
2011-02-01

Target enrollment:

Participant gender:

The purpose of this study is to characterize the safety and efficacy of repeat doses of compound 1278863A in subjects with anemia.

Phase 2

GlaxoSmithKline